Tolerability and outcomes with serial cycles of 28 days of venetoclax in newly diagnosed patients with AML.

Authors: Jesse Sanchez, Michael Kenneth Jones, Katie Julian, Megan Phipps Connor, Rebecca Rezac, Kelsey Marciano, Katelyn Anttila, Connor Sohalski, Ayele Belachew, Matthew Angelos, Christine McMahon, Andrew Kent, Maria Amaya, Marc Schwartz, Jonathan Aaron Gutman, Daniel Aaron Pollyea

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18527

Source: Full article

---

Abstract

e18527